The debate over the use of Embryonic stem cells and the questionable effectiveness of adult stem cells have led many scientists and clinicians to concentrate their energies on umbilical-cord-derived stem cells from healthy newborn babies. Amassing a very respectable track record in terms of safety and clinical utility, cord-blood stem cells can treat many diseases such as multiple sclerosis, amyotrophic lateral sclerosis, stroke, diabetes, heart disease and certain degenerative eye disorders.
|Publisher:||Turner Publishing Company|
|Product dimensions:||6.00(w) x 9.00(h) x 0.60(d)|
About the Author
A pioneering research-oriented physician and director of Steenblock Research Institute. Dr. Steenblock's Therapeutics Medical Clinic offers a comprehensive neuro-rehab program for stroke and leading-edge care for a wide variety of chronic diseases and conditions.
Anthony G. Payne is a biological theoretician and senior science write on staff at the Steenblock Research Institute.